Study on Postoperative Adrenal Function Assessment in Patients With Primary Aldosteronism
1 other identifier
observational
200
0 countries
N/A
Brief Summary
This study employs a prospective, single-center, open, observational research design to evaluate postoperative adrenal cortical function in patients with primary aldosteronism (PA) and to explore indicators predicting postoperative adrenal insufficiency and their predictive efficacy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2024
CompletedFirst Posted
Study publicly available on registry
August 2, 2024
CompletedStudy Start
First participant enrolled
August 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
ExpectedAugust 2, 2024
July 1, 2024
1.6 years
July 27, 2024
August 1, 2024
Conditions
Outcome Measures
Primary Outcomes (10)
The gender and age of the participants
age in years and sex (female or male) of patients
1 day
Participant's weight and height
BMI(body mess index) in kg/m\^2= (weight in kg) /(height in m)\^2
1 day
Patients' baseline hormone level
serum hormone level
1day
Number of Participants with baseline glucose metabolic levels
glucose metabolism, lipid metabolism, liver and kidney function, electrolytes, etc
1 day
Patients' hormone levels at 0 minutes and 120 minutes after preoperative ACTH stimulation test
cortisol and aldosterone levels
1day
Patients' hormone levels at 0 minutes and 120 minutes after postoperative ACTH stimulation test
cortisol and aldosterone levels
1day
Number of Participants with baseline lipid metabolic levels
blood lipid levels
1day
Patients' baseline glucose metabolic levels
0-minute、30-minute、60-minute 、120-minute and 180-minute blood glucose levels after OGTT
1day
Number of Participants with baseline electrolytes levels
sodium, potassium, chloride, calcium, and phosphorus ion levels
1day
Number of Participants with baseline kidney function levels
Creatinine, blood urea nitrogen (BUN), and uric acid levels
1day
Secondary Outcomes (4)
the changes of hormone levels after surgical management
1day
Number of Participants with changes of lipid metabolic levels after surgical management
1day
the changes of glucose metabolic levels after surgical management
1day
Number of Participants with changes of kidney function levels after surgical management
1 day
Eligibility Criteria
This study intends to include 200 patients diagnosed with primary aldosteronism undergoing surgery. An ACTH stimulation test will be performed within one week postoperatively. The participants will be aged 18-75 years, with no gender restrictions. Exclusion criteria include patients using medications that affect adrenal cortical function, patients with a history of adrenal surgery, pregnant or breastfeeding women, and patients with severe underlying diseases (such as liver or kidney failure) that may affect adrenal cortical function
You may qualify if:
- Patients diagnosed with unilateral primary aldosteronism who undergo surgical treatment and have their cortical function assessed by an ACTH stimulation test within one week postoperatively.
You may not qualify if:
- Patients using medications that affect adrenal cortical function.
- Patients with a history of adrenal surgery
- Pregnant or breastfeeding women
- Patients with severe underlying diseases (such as liver or kidney failure) that may affect adrenal cortical function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Biospecimen
patient serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2024
First Posted
August 2, 2024
Study Start
August 15, 2024
Primary Completion
March 15, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
August 2, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share